March 14, 2018 / 12:13 PM / in 9 months

BRIEF-Amneal Gains Approval For Erythromycin Tablets USP

March 14 (Reuters) - Impax Laboratories Inc:

* AMNEAL GAINS APPROVAL FOR ERYTHROMYCIN TABLETS USP

* AMNEAL PHARMACEUTICALS SAYS RECEIVED FDA APPROVAL FOR ERYTHROMYCIN TABLETS USP, 250 MG AND 500 MG STRENGTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below